TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $360,373 | +27.6% | 23,961 | +0.4% | 0.02% | +15.8% |
Q4 2022 | $282,370 | +107.6% | 23,869 | +3.8% | 0.02% | +111.1% |
Q3 2022 | $136,000 | +24.8% | 22,986 | -10.6% | 0.01% | +50.0% |
Q2 2022 | $109,000 | -42.0% | 25,715 | +30.1% | 0.01% | -40.0% |
Q1 2022 | $188,000 | -37.3% | 19,772 | +25.2% | 0.01% | -44.4% |
Q4 2021 | $300,000 | +35.1% | 15,787 | +136.4% | 0.02% | +50.0% |
Q3 2021 | $222,000 | -64.6% | 6,679 | -58.8% | 0.01% | -64.7% |
Q2 2021 | $628,000 | +76.4% | 16,196 | +119.5% | 0.03% | +70.0% |
Q1 2021 | $356,000 | – | 7,380 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |